Lexeo Therapeutics, Inc. (LXEO) Free Cash Flow (2022 - 2023)
Lexeo Therapeutics' Free Cash Flow history spans 2 years, with the latest figure at -$14.0 million for Q4 2023.
- For Q4 2023, Free Cash Flow rose 19.15% year-over-year to -$14.0 million; the TTM value through Dec 2023 reached -$59.5 million, changed N/A, while the annual FY2024 figure was -$81.2 million, 36.28% down from the prior year.
- Free Cash Flow for Q4 2023 was -$14.0 million at Lexeo Therapeutics, roughly flat from -$14.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$13.2 million in Q2 2023 and bottomed at -$18.4 million in Q1 2023.